CytomX Therapeutics (CTMX) Q4 2024 Earnings

7NovConfirmed
Q4 2023
Q2 2024
Q3 2024
Q4 2024
-0.17
-0.06
0.06
0.17

Details

Expected EPS
-0.172328
Actual EPS
0.07
Surprise EPS
0.24
Surprise Percent
+140.62%

Description

CytomX Therapeutics (CTMX) has reported earnings of 0.07 per share for Q4 2024.

0 Comments

Share your thoughts